Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.

Thirty patients infected predominantly by Serratia marcescens and Pseudomonas aeruginosa were treated in an open trial with moxalactam, a broad-spectrum beta-lactam antibiotic. Twenty-three (76%) had a satisfactory microbiological or clinical response. Among 25 patients for whom serum inhibitory con...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Platt, R, Ehrlich, S L, Afarian, J, O'Brien, T F, Pennington, J E, Kass, E H
Формат: Artigo
Язык:Inglês
Опубликовано: 1981
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC181699/
https://ncbi.nlm.nih.gov/pubmed/6458233
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы